LONDON, April 18, 2017 /Weed Wire/ – GW Pharmaceuticals noted that the American Academy of Neurology (AAN) issued a press release today announcing positive results from a second Phase 3 study (GWPCARE3) of Epidiolex.
Tag Archives: American Academy of Neurology
Epilepsy Study Examines Medical Marijuana
The American Academy of Neurology (AAN) disputes medical marijuana’s effectiveness in Medical News Today (MNT) on April 29, 2014. AAN did a comprehensive study regarding the beneficial use of marijuana based on all available evidence. While the study agreed that marijuana is a beneficial treatment for multiple sclerosis (MS), it concluded that there is not enough evidence to declare it beneficial medical treatment for epilepsy, Huntington’s disease, Tourette syndrome or cervical dystonia.